TOI & CareMore care model showcases better cancer care at lower cost

By Nikita Chaurasia  | Date: 2019-09-09

TOI & CareMore care model showcases better cancer care at lower cost
  • The study registered CareMore patients that were newly diagnosed with hematologic and solid malignancies from November 2016 to September 2018.
     
  • The cancer care model which is value-based used LHWs, they are non-physician community members who have obtained specialized training to help patient navigation and care.

The Oncology Institute, (TOI) and Stanford University’s School of Medicine as well as CareMore Health together announced the outcome from a study; improving community capacity to provide value-based cancer care during the end-of-life.

The study examined the effect of interference of having lay health workers, LHWs, for cancer care during the end-of-life. Precisely, the study evaluated the use of healthcare at life’s last month and its effect on financial burden and quality care for patients.

The study registered CareMore patients that were newly diagnosed with hematologic and solid malignancies from November 2016 to September 2018. The study matched results to a controlled set of all patients detected with cancer in the year earlier to intervention.

The cancer care model which is value-based used LHWs, they are non-physician community members obtained specialized training to help in patient navigation and care. The study found no difference in living between the control groups of patients, while the patients getting the value-based care witnessed greater quality along with cancer care at end-of-life.

The latter group of patients had 40% lesser inpatient admissions, 75% lesser visits to emergency department at the last month of their life, increased hospice use of 45% was witnessed, 40% fewer acute care service deaths and median totalized healthcare costs reduced by 25% from diagnosis till death.

Assistant prof. of medicine at Stanford University School for Medicine and the head investigator of the study, Manali Patel, MD, MPH stated that due to this trial the care model which is value-based developed by the group at Stanford and applied by the Oncology Institute is connected with significant enhancements in patient care at the life’s end.

 

Source credit: https://www.businesswire.com/news/home/20190907005023/en/Study-Demonstrates-Significantly-Quality-Cancer-Care-Costs

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More >>

More News By Nikita Chaurasia

Swiftly achieves Unicorn status with $100M Series C led by BRV Capital

Swiftly achieves Unicorn status with $100M Series C led by BRV Capital

By Nikita Chaurasia

Swiftly Systems has reportedly achieved unicorn status, securing in funding through a Series C round. The prominent BRV Capital Management led this funding initiative. According to the earlier reports, Swiftly was adopted by hundreds of consumer b...

Rainforest nations unify to demand cash for climate & biodiversity preservation

Rainforest nations unify to demand cash for climate & biodiversity preservation

By Nikita Chaurasia

As per the reports, twelve nations with rainforests united to establish a collective initiative aiming to address climate change and safeguard biodiversity at summit held in Brazil. The declaration, titled "United for Our Forests," emerged ...

AI Chatbot, Llama 2, unveiled by Meta for commercial use via Microsoft

AI Chatbot, Llama 2, unveiled by Meta for commercial use via Microsoft

By Nikita Chaurasia

Meta Platforms has recently introduced Llama 2, an artificial intelligence large language model, for commercial use in collaboration with major cloud providers like Microsoft. Instead of charging for access or usage, Meta aims to share the model with...

Moderna signs agreement to explore mRNA medicines in China

Moderna signs agreement to explore mRNA medicines in China

By Nikita Chaurasia

Moderna Inc, a leading vaccine manufacturer, reportedly announced on Wednesday that it has entered into a memorandum of understanding (MoU) and a land collaboration agreement aimed at exploring opportunities for researching, developing, and producing...

Nike and Epic Games collaborate to launch Airphoria NFT in Fortnite

Nike and Epic Games collaborate to launch Airphoria NFT in Fortnite

By Nikita Chaurasia

The American footwear design & manufacturing company, Nike and Epic Games, the creators of the popular online game Fortnite, have joined forces in an exciting new collaboration. The partnership aims to bring about a groundbreaking change in the d...